Pharmacist impact on pediatric vaccination errors and missed opportunities in the setting of clinical decision

Insights

Pharmacists significantly reduced missed vaccination opportunities in pediatric primary care. Clinical decision support alone had a higher error rate, highlighting the vital role of pharmacists in pediatric vaccination.

Area of Science:

  • Pediatric Primary Care
  • Clinical Pharmacy
  • Vaccination

Background:

  • Clinical decision support (CDS) systems aim to improve vaccination accuracy.
  • The role of pharmacists in conjunction with CDS in pediatric vaccination is not fully understood.

Purpose of the Study:

  • To evaluate the impact of a clinical pharmacist and CDS on vaccination errors and missed opportunities in pediatric primary care.
  • To compare a clinic with a pharmacist and CDS to a clinic with CDS alone.

Main Methods:

  • A retrospective chart review of 1020 patient encounters across two urban pediatric primary care clinics.
  • Vaccination errors and missed opportunities were compared between a clinic with a pharmacist and CDS and a clinic with CDS alone.

Main Results:

  • The vaccination error rate was 0.4% in the CDS-only group versus 0% in the pharmacist plus CDS group (P=0.4995).
  • Missed vaccination opportunities were significantly higher in the CDS-only group (51 encounters) compared to the pharmacist plus CDS group (30 encounters; P=0.015).

Conclusions:

  • While CDS reduces errors, it cannot be solely relied upon for pediatric vaccination recommendations due to configuration limitations.
  • Pharmacists are crucial for ensuring appropriate pediatric vaccination in primary care settings.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
56
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
446